Search Results 251-260 of 5774 for albumin

  1. Mayo Clinic

    ... . VID-20207893. Home; Artificial Liver Ready for Human Testing - Bioartificial liver. Double your impact on cancer!

  2. A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    Patient must have adequate nutritional status with Body Mass Index (BMI) > 18 kg/m^2 and body weight of > 40 kg with serum albumin > 3 g/dL. Baseline ...

  3. Shear Wave Elastograph and Contrast Enhanced Ultrasound for the Treatment of Lymphedema - Mayo Clinic

    Participation eligibility · Pregnant or nursing women. · Known or suspected hypersensitivity to microbubble contrast agent, perflutren, blood products, albumin, ...

  4. Trial Using Keytruda as Initial Therapy in the Treatment of Advanced Mycosis Fungoides - Mayo Clinic

    Albumin > 2.5 mg/dL;; Serum creatinine ≤ 1.5 x upper limit of normal (ULN) OR Measured or calculated creatinine clearance ≥ 60 ml/min for subject with ...

  5. Study Evaluating the Safety and Efficacy of Semaglutide, and the Fixed-Dose Combination of Cilofexor and Firsocostat, Alone and in Combination, in Participants With Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    - Serum albumin ≥ 3.5 g/dL; - Serum Alkaline Phosphatase (ALP) ≤ 2 x ULN. - BMI ≥ 23 kg/m^2 at screening. Key Exclusion Criteria: - Prior history of ...

  6. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Stage 3 Liver Fibrosis - Mayo Clinic

    Serum albumin < 3.5 g/ dL;; Platelet count < 100 × 103/μL;; International normalized ratio (INR) > 1.4, unless due to therapeutic anticoagulation;; Fasting ...

  7. Study to Evaluate CCS1477 in Haematological Malignancies - Mayo Clinic

    Serum albumin > 2.5 g/dL. Exclusion Criteria: Any investigational agent, chemotherapy, immunotherapy or anticancer agents from a previous clinical study ...

  8. A Study Measuring Protein Levels and Blood Vessel Stiffness in Human Lungs with Aging - Mayo Clinic

    The purpose of this study is to assess the effect of aging on the blood vessels of the lungs by focusing on the proteins involved in contraction of smooth ...

  9. Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer - Mayo Clinic

    - Serum albumin >= 30 g/L (3.0 g/dL) (obtained =< 28 days prior to randomization) - For subjects not receiving therapeutic anticoagulation: international ...

  10. Mayo Clinic

    ... . IMG-20457598. Home; cc-mobile-stem-cell-research_mobile. Double your impact on cancer! Give Now. Make a gift before July 31 and it can be doubled in ...